Despite growing evidence linking vitamin D pathway genes with metabolic diseases (20–23), the role of specific variants in CYP27A1, CYP2R1, and GC in the susceptibility and progression of DKD remains largely unexplored, underscoring the need for further investigations. This evidence concerns the gene CYP2R1 and diabetic kidney disease.